Is It Time to Implement Adjuvant Targeted Therapy in EGFR-Mutant Non-Small-Cell Lung Cancer?

Article

JCO precision oncology - 1 Jan 2021

Kulkarni Amit A, Naqash Abdul Rafeh, Puri Sonam, Dienstmann Rodrigo

Abstract excerpt

No abstract is available from the source.

Community interpretation

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.